As Congress battles over government drug price negotiation, new poll finds strong support on both sides of the aisle
More than 80% of Americans “strongly favor” or “somewhat favor” allowing the federal government to negotiate with drug companies, including 92% of Democrats and 76% of Republicans polled by the Kaiser Family Foundation late last month and earlier this month.
The poll released Tuesday morning comes as Congress remains deadlocked on how to find a way to give drug price negotiating power to Medicare, as part of an effort to help pay for a larger social spending bill from the Democrats. With only a slim majority in the Senate, and Pelosi’s planned vote deadline coming up quickly at the end of the month, Democrats seem to be repeating their past failures, finding holes in their bucket of support.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.